Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 233

    1.

    Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group.

    Alarcón GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR, St Clair EW, Sundy JS, Alexander RW, Smith GJ, Axiotis CA.

    Ann Intern Med. 1997 Sep 1;127(5):356-64.PMID: 9273826 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.

    Kremer JM, Alarcón GS, Weinblatt ME, Kaymakcian MV, Macaluso M, Cannon GW, Palmer WR, Sundy JS, St Clair EW, Alexander RW, Smith GJ, Axiotis CA.

    Arthritis Rheum. 1997 Oct;40(10):1829-37. Review.PMID: 9336418 [PubMed - indexed for MEDLINE]Related articles

    3.

    Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.

    Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE.

    J Rheumatol. 2006 Feb;33(2):248-55. Epub 2005 Dec 15.PMID: 16358365 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis.

    Bernatsky S, Clarke AE, Suissa S.

    Arch Intern Med. 2008 Feb 25;168(4):378-81.PMID: 18299492 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Methotrexate, liver and rheumatoid arthritis in tropical areas]

    Diouf ML, Diallo S, Mbengue M, Moreira-Diop T.

    Sante. 2001 Jul-Sep;11(3):195-200. Review. French. PMID: 11641084 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.

    van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE.

    Arthritis Res Ther. 2006;8(5):R151.PMID: 16984661 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

    Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Li T, Ge Z, Becker JC, Westhovens R.

    Ann Intern Med. 2006 Jun 20;144(12):865-76.PMID: 16785475 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

    Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F.

    Lancet. 2002 Apr 6;359(9313):1173-7.PMID: 11955534 [PubMed - indexed for MEDLINE]Related articles

    10.

    Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis.

    Taniguchi K, Usui Y, Matsuda T, Suzuki S, Fujiki K, Yakusiji F, Tomiyama J, Kinoshita K, Ilzuka H, Kuga Y.

    Int J Clin Pharmacol Res. 2005;25(3):101-5.PMID: 16366417 [PubMed - indexed for MEDLINE]Related articles

    11.

    Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice.

    Taniguchi A, Urano W, Tanaka E, Furihata S, Kamitsuji S, Inoue E, Yamanaka M, Yamanaka H, Kamatani N.

    Pharmacogenet Genomics. 2007 Jun;17(6):383-90.PMID: 17502830 [PubMed - indexed for MEDLINE]Related articles

    12.

    Infliximab therapy in established rheumatoid arthritis: an observational study.

    Voulgari PV, Alamanos Y, Nikas SN, Bougias DV, Temekonidis TI, Drosos AA.

    Am J Med. 2005 May;118(5):515-20.PMID: 15866254 [PubMed - indexed for MEDLINE]Related articles

    13.

    Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery.

    Grennan DM, Gray J, Loudon J, Fear S.

    Ann Rheum Dis. 2001 Mar;60(3):214-7.PMID: 11171680 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.

    Suissa S, Hudson M, Ernst P.

    Arthritis Rheum. 2006 May;54(5):1435-9.PMID: 16645972 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.

    Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Mimori T, Akizuki M, Ikeda Y.

    J Rheumatol. 1997 Dec;24(12):2299-303.PMID: 9415631 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis]

    Ohosone Y, Okano Y, Kameda H, Hama N, Matsumura M, Nojima T, Nakamura K, Kuwana M, Ogasawara T, Hirakata M, Yoshida T, Mimori T, Akizuki M, Ikeda Y.

    Ryumachi. 1997 Feb;37(1):16-23. Japanese. PMID: 9128419 [PubMed - indexed for MEDLINE]Related articles

    17.

    Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.

    De La Mata J, Blanco FJ, Gómez-Reino JJ.

    Ann Rheum Dis. 1995 Nov;54(11):881-5.PMID: 7492236 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.

    Wolfe F, Michaud K.

    Arthritis Rheum. 2004 Jun;50(6):1740-51.PMID: 15188349 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

    Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I.

    Arch Intern Med. 1999 Nov 22;159(21):2542-50.PMID: 10573044 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.

    Kent PD, Luthra HS, Michet C Jr.

    J Rheumatol. 2004 Sep;31(9):1727-31.PMID: 15338491 [PubMed - indexed for MEDLINE]Related articles